Click Here for 5% Off Your First Aladdin Purchase!

NTP42 , CAS No.N612431, Antagonist of TP receptor

  • Moligand™
Item Number
N612431
Grouped product items
SKUSizeAvailabilityPrice Qty
N612431-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
N612431-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90
View related series
TP receptor Antagonist

Basic Description

SynonymsNTP42|2055599-51-2|N-(tert-Butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide|NTP-42|2057H3EG0S|1-tert-butyl-3-[5-cyano-2-[3-[4-(difluoromethoxy)phenyl]phenoxy]phenyl]sulfonylurea|Benzenesulfonamide, 5-cyano-2-((4
GradeMoligand™
Action TypeANTAGONIST
Mechanism of actionAntagonist of TP receptor

Associated Targets

TBXA2R Tclin Thromboxane A2 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 1-tert-butyl-3-[5-cyano-2-[3-[4-(difluoromethoxy)phenyl]phenoxy]phenyl]sulfonylurea
INCHI InChI=1S/C25H23F2N3O5S/c1-25(2,3)29-24(31)30-36(32,33)22-13-16(15-28)7-12-21(22)34-20-6-4-5-18(14-20)17-8-10-19(11-9-17)35-23(26)27/h4-14,23H,1-3H3,(H2,29,30,31)
InChi Key RIIKDGPBTPECSW-UHFFFAOYSA-N
Canonical SMILES N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F
Isomeric SMILES CC(C)(C)NC(=O)NS(=O)(=O)C1=C(C=CC(=C1)C#N)OC2=CC=CC(=C2)C3=CC=C(C=C3)OC(F)F
PubChem CID 124147085

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Mulvaney EP, Reid HM, Bialesova L, Bouchard A, Salvail D, Kinsella BT.  (2020)  NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension..  BMC Pulm Med,  20  (1): (85).  [PMID:32252727]
2. Mulvaney EP, Reid HM, Bialesova L, Mendes-Ferreira P, Adão R, Brás-Silva C, Kinsella BT.  (2020)  Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension..  Eur J Pharmacol,  889  (3): (173658).  [PMID:33121950]

Solution Calculators